Shi M - Search Results

1

Remodeling Chondroitin-6-Sulfate-Mediated Immune Exclusion Enhances Anti-PD-1 Response in Colorectal Cancer with Microsatellite Stability.

Wu Q, Huang Q, Jiang Y, Sun F, Liang B, Wang J, Hu X, Sun M, Ma Z, Shi Y, Liang Y, Tan Y, Zeng D, Yao F, Xu X, Yao Z, Li S, Rong X, Huang N, Sun L, Liao W, Shi M. Wu Q, et al. Among authors: shi m, shi y. Cancer Immunol Res. 2022 Feb;10(2):182-199. doi: 10.1158/2326-6066.CIR-21-0124. Epub 2021 Dec 21. Cancer Immunol Res. 2022. PMID: 34933913 Free PMC article.

2

[Effect of percutaneous chemotherapy pump placement for portal vein chemotherapy on hepatic metastasis of colorectal cancer].

Liao WJ, Shi M, Zheng H, Luo RC. Liao WJ, et al. Among authors: shi m. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Feb;28(2):282-3. Nan Fang Yi Ke Da Xue Xue Bao. 2008. PMID: 18250064 Chinese.

3

Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin.

Luo W, Liao WJ, Ma L, Huang YT, Shi M, Wen Q, Wang XN. Luo W, et al. Among authors: shi m. Cancer Immunol Immunother. 2010 Feb;59(2):247-56. doi: 10.1007/s00262-009-0745-0. Epub 2009 Aug 4. Cancer Immunol Immunother. 2010. PMID: 19652968 Free PMC article. Clinical Trial.

4

[Clinical value of (18)F-FDG positron emission tomography-computed tomography in local liver neoplasm ablation].

Liao WJ, Wu HB, Chen JZ, Shi M, You CX, Wang QS. Liao WJ, et al. Among authors: shi m. Nan Fang Yi Ke Da Xue Xue Bao. 2009 Aug;29(8):1641-2. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19726317 Chinese.

5

[Short-term therapeutic effect and safety of endostar combined with XELIRI regimen in the treatment of advanced colorectal cancer].

Liao WJ, Shen P, Wu Wy, Shi M, Luo RC. Liao WJ, et al. Among authors: shi m. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Apr;30(4):813-4. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20423856 Clinical Trial. Chinese.

6

[Ultrasound-mediated microbubble destruction enhances LMP-1 gene transfection into dendritic cells in vivo].

Xu RF, Shi M, You CX, Lü CW, Luo RC, Liao WJ. Xu RF, et al. Among authors: shi m. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Oct;30(10):2327-9, 2332. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20965837 Chinese.

7

Local recurrence of hepatocellular carcinoma after radiofrequency ablation.

Liao WJ, Shi M, Chen JZ, Li AM. Liao WJ, et al. Among authors: shi m. World J Gastroenterol. 2010 Oct 28;16(40):5135-8. doi: 10.3748/wjg.v16.i40.5135. World J Gastroenterol. 2010. PMID: 20976853 Free PMC article. Review.

8

Normalization of T cell receptor repertoire diversity in patients with advanced colorectal cancer who responded to chemotherapy.

Luo W, Liao WJ, Huang YT, Shi M, Zhang Y, Wen Q, Zhou MQ, Ma L. Luo W, et al. Among authors: shi m. Cancer Sci. 2011 Apr;102(4):706-12. doi: 10.1111/j.1349-7006.2011.01868.x. Epub 2011 Feb 20. Cancer Sci. 2011. PMID: 21235683 Free article. Clinical Trial.

9

Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation.

Luo W, Liao WJ, Huang YT, Shi M, Zhang Y, Wen Q, Zhou MQ, Ma L. Luo W, et al. Among authors: shi m. Cell Immunol. 2011;270(1):47-52. doi: 10.1016/j.cellimm.2011.03.024. Epub 2011 Mar 29. Cell Immunol. 2011. PMID: 21497799

10

The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.

Zuo Q, Shi M, Chen J, Liao W. Zuo Q, et al. Among authors: shi m. Biomed Pharmacother. 2011 Jun;65(3):168-74. doi: 10.1016/j.biopha.2011.02.005. Epub 2011 May 5. Biomed Pharmacother. 2011. PMID: 21602020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,956 results

Search Page

Filters